| A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments (NCT00006211) | Agouron Pharmaceuticals | 2000-02-01 |
| Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide (NCT00213031) | Population Council | 2000-02-01 |
| Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis (NCT00012467) | InterMune | 2000-01-01 |
| Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy (NCT00004985) | Agouron Pharmaceuticals | 2000-01-01 |
| Long-Term Data Collection From Participants in Adult AIDS Clinical Trials (NCT00001137) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2000-01-01 |
| Once-Daily Drug Regimen for HIV-Infected Patients (NCT00001968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-01-01 |
| A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection (NCT00002453) | Gilead Sciences | 1999-12-01 |
| Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs (NCT00005000) | Agouron Pharmaceuticals | 1999-12-01 |
| Hormonal Birth Control and the Risk of Acquiring HIV (NCT00006324) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1999-12-01 |
| Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients (NCT02239835) | Boehringer Ingelheim | 1999-12-01 |
| Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen (NCT02191332) | Boehringer Ingelheim | 1999-12-01 |
| Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment (NCT00004584) | Bristol-Myers Squibb | 1999-12-01 |
| TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz (NCT00023413) | Centers for Disease Control and Prevention | 1999-11-01 |
| Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA (NCT00273403) | The New York Academy of Medicine | 1999-11-01 |
| Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination (NCT00001132) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-11-01 |
| Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients (NCT00004998) | Agouron Pharmaceuticals | 1999-11-01 |
| Treatment of Advanced AIDS Patients With Dextrin Sulfate (NCT00004987) | Steinhart Medical Associates | 1999-10-01 |
| The Biology of HIV Transmission (NCT00001092) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| A Study to Monitor Patients With Primary or Early HIV Infection (NCT00000911) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients (NCT00002448) | Hoffmann-La Roche | 1999-10-01 |
| A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults (NCT00004585) | Glaxo Wellcome | 1999-10-01 |
| Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission (NCT00213018) | Population Council | 1999-10-01 |
| Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients (NCT00069498) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV (NCT00001119) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| A Study to Compare Two Anti-HIV Drug Combinations (NCT00002447) | Hoffmann-La Roche | 1999-10-01 |
| Metabolism and Body Shape of Healthy Children and Children With Chronic Infections (NCT00001142) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1999-10-01 |
| Outcomes of Anti-HIV Therapy During Early HIV Infection (NCT00001093) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome (NCT00006185) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-09-01 |
| Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients (NCT00010491) | National Center for Complementary and Integrative Health (NCCIH) | 1999-09-01 |
| Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users (NCT00183768) | Butler Hospital | 1999-09-01 |
| Parents Matter!: Interventions to Promote Effective Parent-Child Communication (NCT00137943) | Centers for Disease Control and Prevention | 1999-09-01 |
| A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients (NCT00005106) | Glaxo Wellcome | 1999-09-01 |
| HIV, Abuse, and Psychiatric Disorders Among Youth (NCT00603369) | Rhode Island Hospital | 1999-09-01 |
| Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs (NCT00004852) | Glaxo Wellcome | 1999-09-01 |
| A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1 (NCT00001121) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-08-01 |
| Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients (NCT00004999) | Agouron Pharmaceuticals | 1999-08-01 |
| Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy (NCT00002449) | Chiron Corporation | 1999-08-01 |
| Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients (NCT00001110) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-08-01 |
| A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00002362) | Triangle Pharmaceuticals | 1999-08-01 |
| TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB (NCT00023348) | Centers for Disease Control and Prevention | 1999-07-01 |
| Treatment of Acute HIV Infection to Preserve Immune Function (NCT00055094) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-07-01 |
| Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen (NCT00002429) | Bristol-Myers Squibb | 1999-07-01 |
| Safety and Effectiveness of a Combination Anti-HIV Drug Treatment (NCT00005018) | Glaxo Wellcome | 1999-07-01 |
| A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs (NCT00002442) | Glaxo Wellcome | 1999-06-01 |
| A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients (NCT00005663) | Glaxo Wellcome | 1999-06-01 |
| Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients (NCT02184286) | Boehringer Ingelheim | 1999-05-01 |
| Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV (NCT00000940) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-05-01 |
| A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss (NCT00000925) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-05-01 |
| Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults (NCT00002427) | Research Institute for Genetic and Human Therapy | 1999-05-01 |
| A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults (NCT00002239) | Hoffmann-La Roche | 1999-05-01 |
| Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients (NCT02184299) | Boehringer Ingelheim | 1999-04-01 |
| Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women (NCT02181933) | Boehringer Ingelheim | 1999-04-01 |
| KSHV Infection in Blood Donors From Texas (NCT00006310) | The University of Texas Health Science Center at San Antonio | 1999-04-01 |
| Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults (NCT02182765) | Boehringer Ingelheim | 1999-04-01 |
| A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients (NCT00002245) | Glaxo Wellcome | 1999-04-01 |
| Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs (NCT00002240) | Bristol-Myers Squibb | 1999-03-01 |
| Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) (NCT00002224) | Bristol-Myers Squibb | 1999-03-01 |
| A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy (NCT00004583) | Abbott | 1999-03-01 |
| A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir (NCT00002423) | Glaxo Wellcome | 1999-03-01 |
| A Study of the Long-Term Outcomes of HIV-Positive Patients (NCT00000932) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-03-01 |
| Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand (NCT00006327) | VaxGen | 1999-03-01 |
| A Study Comparing Two Forms of Didanosine in HIV-infected Patients (NCT00002360) | Bristol-Myers Squibb | 1999-03-01 |
| Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir (NCT02249130) | Boehringer Ingelheim | 1999-03-01 |
| Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults (NCT00196599) | ANRS, Emerging Infectious Diseases | 1999-02-01 |
| TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen (NCT00023361) | Centers for Disease Control and Prevention | 1999-02-01 |
| CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes (NCT00966160) | University of Cologne | 1999-01-01 |
| Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients (NCT02238314) | Boehringer Ingelheim | 1999-01-01 |
| Motivation and Patch Treatment for HIV-positive Smokers (NCT00551720) | National Institute on Drug Abuse (NIDA) | 1999-01-01 |
| Tuberculosis in HIV Infected Patients in Uganda (NCT00057421) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-11-01 |
| Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients (NCT02184078) | Boehringer Ingelheim | 1998-10-01 |
| Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults (NCT00110578) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-09-01 |
| Vitamin A Therapy for Tuberculosis (NCT00057434) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-09-01 |
| Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients (NCT00002446) | Schering-Plough | 1998-08-01 |
| Longitudinal Study of Ocular Complications of AIDS (LSOCA) (NCT00000168) | Johns Hopkins Bloomberg School of Public Health | 1998-08-01 |
| MEMA Kwa Vijana Trial: Impact of an Adolescent Sexual and Reproductive Health Intervention in Mwanza, Tanzania (NCT00248469) | London School of Hygiene and Tropical Medicine | 1998-07-01 |
| Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent (NCT00001717) | National Institutes of Health Clinical Center (CC) | 1998-07-01 |
| Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe (NCT00390949) | Imperial College London | 1998-07-01 |
| Genetic Susceptibility to Oncogenic Viruses (NCT00341484) | National Cancer Institute (NCI) | 1998-06-01 |
| A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers (NCT00001699) | National Cancer Institute (NCI) | 1998-06-01 |
| The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 (NCT00000825) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-05-01 |
| Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women (NCT02182791) | Boehringer Ingelheim | 1998-04-01 |
| A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection (NCT00004579) | Walter Reed Army Institute of Research (WRAIR) | 1998-04-01 |
| A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs (NCT00002411) | Bristol-Myers Squibb | 1998-03-01 |
| Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 (NCT00000948) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-02-01 |
| To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI). (NCT00007709) | US Department of Veterans Affairs | 1998-01-01 |
| Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems (NCT00001097) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-12-01 |
| ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects (NCT00004578) | Abbott | 1997-11-01 |
| Development of a New HIV Vaccine (NCT00051922) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 (NCT00000889) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex (NCT00002246) | Bristol-Myers Squibb | 1997-10-01 |
| Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children (NCT00000893) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations (NCT00001681) | National Cancer Institute (NCI) | 1997-10-01 |
| Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy (NCT00000883) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients (NCT00057486) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-09-01 |
| Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants (NCT00000917) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-09-01 |
| A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients (NCT00299338) | Samaritan Pharmaceuticals, Inc | 1997-09-01 |
| A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART (NCT00000874) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis (NCT00001646) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| Determination of HIV-1 Production by the Prostate (NCT00001584) | National Cancer Institute (NCI) | 1997-07-01 |
| Growth Hormone in the Treatment of HIV-Associated Wasting (NCT00489528) | EMD Serono | 1997-07-01 |